The peripheral angioplasty market size is projected to be worth US$ 3.4 billion in 2023. The market is likely to surpass US$ 7.2 billion by 2033 at a CAGR of 7.7% during the forecast period. A minimally invasive treatment called peripheral angioplasty, sometimes referred to as peripheral arterial angioplasty or percutaneous transluminal angioplasty (PTA), is used to treat peripheral artery disease (PAD). It is a procedure used in medicine to unblock arteries in the peripheral vascular system that are clogged or narrowed, especially in the lower extremities (legs, feet, and ankles).
A small, flexible catheter with a deflated balloon connected to its tip is introduced into the troubled artery during peripheral angioplasty. Using imaging methods like fluoroscopy or angiography, the catheter is directed to the location of the obstruction or constriction. Once in place, the balloon is inflated to widen the arterial lumen and compress plaque or fatty deposits against the artery walls, allowing normal blood flow to resume. In rare circumstances, a stent (a tiny
Other Drivers Propelling the Demand for Peripheral Angioplasty include:
Challenges for Companies /Manufacturers in the Peripheral Angioplasty Market:
Opportunities in the Peripheral Angioplasty Industry:
Latest Trends in the Peripheral Angioplasty Market:
| Attributes | Details |
|---|---|
| Peripheral Angioplasty Market Size (2023) | US$ 3.4 billion |
| Peripheral Angioplasty Market Projected Size (2033) | US$ 7.2 billion |
| Value CAGR (2023 to 2033) | 7.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2012 to 2022, the global peripheral angioplasty market experienced a CAGR of 5.4%, reaching a market size of US$ 3.4 billion in 2023.
From 2012 to 2022, Over the years, there has been consistent expansion in the peripheral angioplasty market. The market has grown dramatically as a result of improvements in medical device technology, rising awareness of peripheral artery disease (PAD), and an ageing population. Typically, the historic period includes data from the previous ten years. During this time, the market expanded significantly as a result of the increased incidence of PAD and the rising popularity of minimally invasive procedures.
Future Forecast for Peripheral Angioplasty Industry:
Looking ahead, the global peripheral angioplasty industry is expected to rise at a CAGR of 7.7% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 7.2 billion by 2033.
The market for peripheral angioplasty is expected to continue growing in the years to come, according to the forecast. The market is anticipated to expand as a result of factors such the ageing population, rising PAD prevalence, device technology developments, and growing public awareness of the advantages of minimally invasive procedures.
| Country | The United States |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 2.3 billion |
| CAGR % 2023 to End of Forecast (2033) | 6.8% |
The peripheral angioplasty industry in the United States is expected to reach a market size of US$ 2.3 billion by 2033, expanding at a CAGR of 6.8%. Early diagnosis and treatments have been made possible by greater awareness of peripheral artery disease and the symptoms it is linked with. More patients who need peripheral angioplasty treatments have been found thanks to screening programs and public health initiatives that attempt to inform people about the dangers and symptoms of PAD. The management of PAD and the expansion of the market depend on prompt diagnosis and treatment.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 229.3 million |
| CAGR % 2023 to End of Forecast (2033) | 4.2% |
The peripheral angioplasty industry in the United Kingdom is expected to reach a market value of US$ 229.3 million, expanding at a CAGR of 4.2% during the forecast period. The presence of the National Health Service (NHS) in the UK plays a significant role in the growth of the peripheral angioplasty market. The NHS provides comprehensive healthcare coverage, including peripheral angioplasty procedures, making them accessible to a large population. The support of the NHS in terms of infrastructure, reimbursement, and access to healthcare services contributes to the growth of the market.
| Country | China |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 732.1 million |
| CAGR % 2023 to End of Forecast (2033) | 13.0% |
The peripheral angioplasty industry in China is anticipated to reach a market size of US$ 732.1 million, moving at a CAGR of 13.0% during the forecast period. China's rising healthcare expenditure plays a vital role in the growth of the peripheral angioplasty market. The government's commitment to expanding healthcare coverage, improving the quality of care, and addressing the burden of chronic diseases supports the demand for peripheral angioplasty procedures. Increased healthcare expenditure ensures better access to medical services and devices, including peripheral angioplasty devices.
| Country | Japan |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 448.8 million |
| CAGR % 2023 to End of Forecast (2033) | 9.0% |
The peripheral angioplasty industry in Japan is estimated to reach a market size of US$ 448.8 million by 2033, thriving at a CAGR of 9.0%. The Japanese healthcare system provides universal health coverage through the public health insurance system. This coverage includes reimbursement for peripheral angioplasty procedures, making them accessible to a wide population. Favorable reimbursement policies ensure the availability and affordability of peripheral angioplasty devices, driving market growth.
| Country | South Korea |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 143.7 million |
| CAGR % 2023 to End of Forecast (2033) | 8.7% |
The peripheral angioplasty industry in South Korea is expected to reach a market size of US$ 143.7 million, expanding at a CAGR of 8.7% during the forecast period. In South Korea, partnerships between medical device producers, healthcare providers, and research organizations foster innovation and commercial expansion. Clinical trials, knowledge exchange, and research and development are all made possible via partnerships. Collaborations help to enhance peripheral angioplasty technologies and encourage the use of these tools in clinical settings.
Principal Consultant
The balloon catheters are expected to dominate the peripheral angioplasty industry with a CAGR of 5.2% from 2023 to 2033. Balloon catheters are a fundamental component of peripheral angioplasty procedures. They are used to dilate narrowed or blocked blood vessels in the peripheral arteries, restoring blood flow to the affected area. The effectiveness of balloon catheters in achieving vessel dilation makes them an indispensable tool in the field of peripheral angioplasty.
The hospitals segments are expected to dominate the peripheral angioplasty industry with a CAGR of 6.3% from 2023 to 2033. Hospitals provide the necessary infrastructure and resources to perform peripheral angioplasty procedures. They house specialized catheterization laboratories equipped with advanced imaging technologies, such as fluoroscopy and angiography, that aid in the precise visualization and guidance during the procedure. Access to these advanced treatment facilities in hospitals ensures the availability of peripheral angioplasty services to patients.
The peripheral angioplasty sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Strategic partnerships and alliances with other businesses are regularly formed by major players in an industry to take advantage of each other's advantages and expand their market reach. Through such arrangements, businesses may also obtain access to new technologies and markets.
In emerging economies like China and India, the market for peripheral angioplasty is growing quickly. To boost their presence in these regions, major companies are expanding their distribution networks and setting up local manufacturing units.
Mergers and acquisitions are frequently used by key players in the peripheral angioplasty business to consolidate their market position, extend their product range, and gain access to new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Peripheral Angioplasty Market:
The hospital sector holds high revenue potential.
The United States, China and the United Kingdom dominate the global market.
The market is forecast to register a CAGR of 7.7% through 2033.
The market registered a CAGR of 5.4% from 2018 to 2022.
The high quality care to enhance patients outcomes are the current market trends.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption Analysis
4.2. Number of Procedures
4.3. Reimbursement Scenario
4.4. Regulatory Landscape
4.5. PESTEL Analysis
4.6. Porter’s Analysis
4.7. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Diagnosis Rate (%)
5.2.3. Increasing Prevalence of Peripheral Artery Disease
5.2.4. Favourable Government Regulations
5.2.5. Rising Demand for Bypass Surgeries
5.2.6. Cost Per Stent
5.2.7. Technological Advancements in Catheters
5.2.8. Frequency of Product Approvals
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033
6.1. Historical Volume (in Units) Analysis, 2012 to 2022
6.2. Current and Future Volume (in Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2012 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033
9.3.1. Balloon Catheters
9.3.2. Stents
9.3.3. Guidewires
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Cardiac Catheterization Centres
10.4. Market Attractiveness Analysis By End User
11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2012 to 2022
11.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (Middle East & Africa)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
12.3.1. By Country
12.3.1.1. USA
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By End User
12.5. Country Level Analysis & Forecast
12.5.1. USA Market Analysis
12.5.1.1. Introduction
12.5.1.2. Market Analysis and Forecast by Market Taxonomy
12.5.1.2.1. By Product
12.5.1.2.2. By End User
12.5.2. Canada Market Analysis
12.5.2.1. Introduction
12.5.2.2. Market Analysis and Forecast by Market Taxonomy
12.5.2.2.1. By Product
12.5.2.2.2. By End User
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By End User
13.5. Country Level Analysis & Forecast
13.5.1. Brazil Market Analysis
13.5.1.1. Introduction
13.5.1.2. Market Analysis and Forecast by Market Taxonomy
13.5.1.2.1. By Product
13.5.1.2.2. By End User
13.5.2. Mexico Market Analysis
13.5.2.1. Introduction
13.5.2.2. Market Analysis and Forecast by Market Taxonomy
13.5.2.2.1. By Product
13.5.2.2.2. By End User
13.5.3. Argentina Market Analysis
13.5.3.1. Introduction
13.5.3.2. Market Analysis and Forecast by Market Taxonomy
13.5.3.2.1. By Product
13.5.3.2.2. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. France
14.3.1.3. Italy
14.3.1.4. UK
14.3.1.5. Spain
14.3.1.6. Russia
14.3.1.7. BENELUX
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Material
14.4.4. By End User
14.5. Country Level Analysis & Forecast
14.5.1. Germany Market Analysis
14.5.1.1. Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Product
14.5.1.2.2. By End User
14.5.2. France Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Product
14.5.2.2.2. By End User
14.5.3. Italy Market Analysis
14.5.3.1. Introduction
14.5.3.2. Market Analysis and Forecast by Market Taxonomy
14.5.3.2.1. By Product
14.5.3.2.2. By End User
14.5.4. UK Market Analysis
14.5.4.1. Introduction
14.5.4.2. Market Analysis and Forecast by Market Taxonomy
14.5.4.2.1. By Product
14.5.4.2.2. By End User
14.5.5. Spain Market Analysis
14.5.5.1. Introduction
14.5.5.2. Market Analysis and Forecast by Market Taxonomy
14.5.5.2.1. By Product
14.5.5.2.2. By End User
14.5.6. Russia Market Analysis
14.5.6.1. Introduction
14.5.6.2. Market Analysis and Forecast by Market Taxonomy
14.5.6.2.1. By Product
14.5.6.2.2. By End User
14.5.7. BENELUX Market Analysis
14.5.7.1. Introduction
14.5.7.2. Market Analysis and Forecast by Market Taxonomy
14.5.7.2.1. By Product
14.5.7.2.2. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By End User
15.5. Country Level Analysis & Forecast
15.5.1. India Market Analysis
15.5.1.1. Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Product
15.5.1.2.2. By End User
15.5.2. Thailand Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Product
15.5.2.2.2. By End User
15.5.3. Indonesia Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Product
15.5.3.2.2. By End User
15.5.4. Malaysia Market Analysis
15.5.4.1. Introduction
15.5.4.2. Market Analysis and Forecast by Market Taxonomy
15.5.4.2.1. By Product
15.5.4.2.2. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By End User
16.5. Country Level Analysis & Forecast
16.5.1. China Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By End User
16.5.2. Japan Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By End User
16.5.3. South Korea Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Product
16.5.3.2.2. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By End User
17.5. Country Level Analysis & Forecast
17.5.1. Australia Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By End User
17.5.2. New Zealand Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Türkiye
18.3.1.3. Northern Africa
18.3.1.4. South Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By End User
18.5. Country Level Analysis & Forecast
18.5.1. GCC Countries Market Analysis
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By End User
18.5.2. Türkiye Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By End User
18.5.3. Northern Africa Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Product
18.5.3.2.2. By End User
18.5.4. South Africa Market Analysis
18.5.4.1. Introduction
18.5.4.2. Market Analysis and Forecast by Market Taxonomy
18.5.4.2.1. By Product
18.5.4.2.2. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Branding and Promotional Strategies, By Key Players
20.3. Key Development Analysis
20.4. Competition Deep Dive
20.4.1. Boston Scientific Corporation
20.4.1.1. Overview
20.4.1.2. Product Portfolio
20.4.1.3. Key Financials
20.4.1.4. Sales Footprint
20.4.1.5. SWOT Analysis
20.4.1.6. Strategy Overview
20.4.1.6.1. Marketing Strategy
20.4.1.6.2. Product Strategy
20.4.1.6.3. Channel Strategy
20.4.2. Medtronic
20.4.2.1. Overview
20.4.2.2. Product Portfolio
20.4.2.3. Key Financials
20.4.2.4. Sales Footprint
20.4.2.5. SWOT Analysis
20.4.2.6. Strategy Overview
20.4.2.6.1. Marketing Strategy
20.4.2.6.2. Product Strategy
20.4.2.6.3. Channel Strategy
20.4.3. Abbott Laboratories
20.4.3.1. Overview
20.4.3.2. Product Portfolio
20.4.3.3. Key Financials
20.4.3.4. Sales Footprint
20.4.3.5. SWOT Analysis
20.4.3.6. Strategy Overview
20.4.3.6.1. Marketing Strategy
20.4.3.6.2. Product Strategy
20.4.3.6.3. Channel Strategy
20.4.4. Terumo Corporation
20.4.4.1. Overview
20.4.4.2. Product Portfolio
20.4.4.3. Key Financials
20.4.4.4. Sales Footprint
20.4.4.5. SWOT Analysis
20.4.4.6. Strategy Overview
20.4.4.6.1. Marketing Strategy
20.4.4.6.2. Product Strategy
20.4.4.6.3. Channel Strategy
20.4.5. Johnson & Johnson
20.4.5.1. Overview
20.4.5.2. Product Portfolio
20.4.5.3. Key Financials
20.4.5.4. Sales Footprint
20.4.5.5. SWOT Analysis
20.4.5.6. Strategy Overview
20.4.5.6.1. Marketing Strategy
20.4.5.6.2. Product Strategy
20.4.5.6.3. Channel Strategy
20.4.6. Cook Medical
20.4.6.1. Overview
20.4.6.2. Product Portfolio
20.4.6.3. Key Financials
20.4.6.4. Sales Footprint
20.4.6.5. SWOT Analysis
20.4.6.6. Strategy Overview
20.4.6.6.1. Marketing Strategy
20.4.6.6.2. Product Strategy
20.4.6.6.3. Channel Strategy
20.4.7. B. Braun Melsungen AG
20.4.7.1. Overview
20.4.7.2. Product Portfolio
20.4.7.3. Key Financials
20.4.7.4. Sales Footprint
20.4.7.5. SWOT Analysis
20.4.7.6. Strategy Overview
20.4.7.6.1. Marketing Strategy
20.4.7.6.2. Product Strategy
20.4.7.6.3. Channel Strategy
20.4.8. Edwards Lifesciences Corporation
20.4.8.1. Overview
20.4.8.2. Product Portfolio
20.4.8.3. Key Financials
20.4.8.4. Sales Footprint
20.4.8.5. SWOT Analysis
20.4.8.6. Strategy Overview
20.4.8.6.1. Marketing Strategy
20.4.8.6.2. Product Strategy
20.4.8.6.3. Channel Strategy
20.4.9. Becton, Dickinson and Company
20.4.9.1. Overview
20.4.9.2. Product Portfolio
20.4.9.3. Key Financials
20.4.9.4. Sales Footprint
20.4.9.5. SWOT Analysis
20.4.9.6. Strategy Overview
20.4.9.6.1. Marketing Strategy
20.4.9.6.2. Product Strategy
20.4.9.6.3. Channel Strategy
20.4.10. MicroPort Scientific Corporation
20.4.10.1. Overview
20.4.10.2. Product Portfolio
20.4.10.3. Key Financials
20.4.10.4. Sales Footprint
20.4.10.5. SWOT Analysis
20.4.10.6. Strategy Overview
20.4.10.6.1. Marketing Strategy
20.4.10.6.2. Product Strategy
20.4.10.6.3. Channel Strategy
20.4.11. Teleflex Incorporated
20.4.11.1. Overview
20.4.11.2. Product Portfolio
20.4.11.3. Key Financials
20.4.11.4. Sales Footprint
20.4.11.5. SWOT Analysis
20.4.11.6. Strategy Overview
20.4.11.6.1. Marketing Strategy
20.4.11.6.2. Product Strategy
20.4.11.6.3. Channel Strategy
20.4.12. W. L. Gore & Associates
20.4.12.1. Overview
20.4.12.2. Product Portfolio
20.4.12.3. Key Financials
20.4.12.4. Sales Footprint
20.4.12.5. SWOT Analysis
20.4.12.6. Strategy Overview
20.4.12.6.1. Marketing Strategy
20.4.12.6.2. Product Strategy
20.4.12.6.3. Channel Strategy
20.4.13. Biotronik SE & Co. KG
20.4.13.1. Overview
20.4.13.2. Product Portfolio
20.4.13.3. Key Financials
20.4.13.4. Sales Footprint
20.4.13.5. SWOT Analysis
20.4.13.6. Strategy Overview
20.4.13.6.1. Marketing Strategy
20.4.13.6.2. Product Strategy
20.4.13.6.3. Channel Strategy
20.4.14. AngioDynamics, Inc.
20.4.14.1. Overview
20.4.14.2. Product Portfolio
20.4.14.3. Key Financials
20.4.14.4. Sales Footprint
20.4.14.5. SWOT Analysis
20.4.14.6. Strategy Overview
20.4.14.6.1. Marketing Strategy
20.4.14.6.2. Product Strategy
20.4.14.6.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Peripheral Angioplasty Market
